Friday, 23 Mar 2018

You are here

Isolated SS-B Not Associated with Connective Tissue Disease

A one-year prospective study of 624 patients undergoing autoantibody testing for anti-SS-A and/or anti-SS-B autoantibodies finds that isolated anti-SS-B autoantibodies was not associated with features or the diagnosis of any specific connective tissue diseases (CTD).

Isolate SS-B autoantibody positivity (SS-B-positive/SS-A negative autoantibody profile) was found in 84 of 624 patients referred for testing (13.5%). Only 20% were diagnosed with a CTD, including 4 systemic lupus erythematosus (5%), 4 rheumatoid arthritis (5%), 2 idiopathic inflammatory myositis (3%), 1 primary Sjögren's syndrome pSS (1%), 1 systemic sclerosis (1%), 2 undefined CTD (3%), and 1 mixed CTD (1%).

A variety of other non-CTD autoimmune diseases and non-autoimmune diseases were seen in the remaining patients.

Arthralgia was the most frequent finding seen in 10 patients (67%), of whom 3 had arthritis.


The author has no conflicts of interest to disclose related to this subject

Rheumatologists' Comments

Jack: I sure hope that clinicians do not read this abstract and title in a vacuum and assume "isolated SSB is not seen in CTDs!" I certainly have several SLE pts with this (SSB but neg SSA); this study actually had a 20% prevalence of CTD at evaluation. We must remind ourselves that autoantibodies can appear years before dz onset, and Sjogren's syndrome especially can have a slow/gradual onset over many years' time. I would change the wording to "Isolated SSB is seen with CTDs but is not specific for Sjogren's syndrome". Also, my plan for the patient with isolated SSB who does not currently have evidence for a CTD would be: educate the patient about the symptoms of CTD and see me ASAP if any occur, but also, I'd follow the patient clinically over time to see if a CTD does occur in the hopes of catching it at an early, more easily treated stage. (Reference: MR Arbuckle et al. N Engl J Med 2003;349:1526-33)
DT; I posted this as I thought it was thought provoking and your thoughtful comments are appreciated. While only 20% of these isolate SSB patients had a CTD, the smart rheumatologist would and should do as suggest. Counsel, educated, follow and manage Sxs until something more definitive occurs. I beleive we all see such patients, but not much is written about their fate or associations. JJC

More Like This

mTOR Inhibition with Sirolimus Effective in Lupus

Lancet reports that 12 months of sirolimus treatment is associated with improvement in lupus disease activity presumeably by correction of pro-inflammatory T-cell activity.

Plaquenil During Lupus Pregnancy Lessens Flares

A large cohort study of pregnant and non-pregnant women with systemic lupus erythematosus has shown that lupus flares are increased during pregnancy and in the 3  months follwing delivery.

Diet During Pregnancy May Influence Future Allergic or Autoimmune Disease

A systematic review of the literature on the relationship between diet during pregnancy, lactation, or the first year of life suggests that maternal ingestion of probiotic and fish oil supplementation may reduce risk of eczema and allergic sensitization to food, respectively.

Shorter Steroid Courses Effective in ANCA+ Vasculitis

An 8-week course of prednisone plus rituximab (Rituxin) offered good outcomes in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), including complete remission, researchers reported.

Are ANA Tests Unreliable?

Pisetsky and colleagues have reported in the Annals of Rheumatic Disease that ANA tests done on established SLE patients may yield surprisingly disparate results.

While ANA negative lupus was a problem of old assays and the loss of ANA positivity may be seen with chronicity or age, most rheumatologists believe that ANA positivity is an absolute requirement for the diagnosis of systemic lupus erythematosus.